Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Implications of D1 vs D2 Lymphadenectomy in Gastric Cancer: a Propensity Score Matched Analysis

NCT05253430 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.

NCT NCT05253430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Implications of D1 vs D2 Lymphadenectomy in Gastric Cancer: a Propensity Score Matched Analysis
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Phase
Observational
Overall status
Completed
Start date
April 30, 1990
Completion date
February 28, 2021
Enrollment
357 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer